Global Endoscopic Ultrasound Needles Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Aspiration Needles (EUS-FNA), and Biopsy Needles (EUS-FNB).By Application;
Bronchial Needles, and Enteral Needles.By End Users;
Hospitals, Ambulatory Surgical Centers, and Specialty Clinics.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Endoscopic Ultrasound Needles Market (USD Million), 2021 - 2031
In the year 2023, the Global Endoscopic Ultrasound Needles Market was valued at USD 2,600.87 million. The size of this market is expected to increase to USD 3,563.20 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 4.6%.
The global endoscopic ultrasound (EUS) needles market is experiencing robust growth driven by the rising adoption of minimally invasive diagnostic and therapeutic procedures, advancements in endoscopic ultrasound technology, and increasing prevalence of gastrointestinal and pancreatic diseases worldwide. Endoscopic ultrasound, a minimally invasive imaging modality, combines endoscopy and ultrasound to visualize and obtain high-resolution images of internal organs in the gastrointestinal tract, primarily the esophagus, stomach, pancreas, and rectum.
EUS procedures play a vital role in the diagnosis, staging, and treatment planning for various gastrointestinal and pancreatic conditions, including pancreatic cancer, gastrointestinal stromal tumors, submucosal lesions, and lymph node staging. As the demand for accurate and early diagnosis of these diseases continues to rise, so does the demand for EUS needles, which are essential instruments used in EUS-guided fine needle aspiration (FNA) and fine needle biopsy (FNB) procedures.
The growing prevalence of gastrointestinal and pancreatic diseases, particularly cancers, is a key driver propelling the demand for EUS needles. Pancreatic cancer, in particular, is known for its high mortality rate and late-stage diagnosis, emphasizing the critical need for effective diagnostic tools like EUS-FNA/FNB to enable early detection and intervention. The increasing incidence of obesity, lifestyle-related diseases, and aging populations contribute to the rising burden of gastrointestinal disorders, thereby boosting the demand for EUS procedures and needles. Technological advancements in EUS needle design and manufacturing have led to the development of innovative devices that offer improved precision, maneuverability, and sampling quality. Manufacturers are introducing features such as high-definition imaging, enhanced needle tip designs, and compatibility with advanced imaging modalities like contrast-enhanced EUS and elastography, thereby enhancing the diagnostic capabilities of EUS procedures.
Global Endoscopic Ultrasound Needles Market Recent Developments
-
In May 2022, Limaca Medical announced that they had received breakthrough device designation from the FDA for its Precision-GI endoscopic ultrasound biopsy needle. It is an automated, rotational cutting needle aiming to decrease sample tissue fragmentation, inadequate sample amount, and blood contamination.
-
In November 2021, SonoScape Medical launched the latest addition to its endoscopy product line, the linear echoendoscope EG-UC5T, in the format of a webinar in collaboration with the ESGE (European Society of Gastrointestinal Endoscopy) and three globally renowned EUS experts, where experts discussed tricks to achieve a successful EUS-FNA.
-
In October 2021, Micro-Tech Endoscopy launched an enhanced version of the company's endoscopic ultrasound needles named Areus FNA Needle and Trident FNB Needle.
Segment Analysis
The Global Endoscopic Ultrasound (EUS) Needles Market is segmented by Product, Application, End Users and Geography to provide a detailed analysis of its structure and growth dynamics. By product, the market is divided into fine-needle aspiration (FNA) and fine-needle biopsy (FNB) needles. FNA needles dominate the segment due to their widespread use in obtaining cytological samples from lesions in the gastrointestinal (GI) tract, pancreas, and mediastinum. However, FNB needles are gaining traction for their ability to collect histological samples, enabling more accurate diagnoses and comprehensive analysis, particularly in oncology.
Segmentation by application focuses on areas such as oncology, gastrointestinal diseases, and others. Oncology represents the largest application segment, driven by the growing incidence of cancers, particularly pancreatic, esophageal, and gastric cancers. EUS needles play a critical role in diagnosing and staging malignancies, as well as guiding therapeutic interventions. In gastrointestinal diseases, EUS needles are used to diagnose inflammatory conditions and cystic lesions, further expanding their clinical applications.
In terms of end users, hospitals account for the largest market share due to their advanced infrastructure and expertise in performing complex EUS-guided procedures. Ambulatory surgical centers and specialty clinics are emerging as significant players, benefiting from shorter procedure times and lower costs. Geographically, North America leads the market due to its robust healthcare system and high adoption of advanced diagnostic tools. Meanwhile, the Asia-Pacific region is experiencing rapid growth, fueled by increasing healthcare investments, rising awareness of minimally invasive diagnostics, and the growing prevalence of GI cancers and other conditions requiring EUS-guided interventions.
Global Endoscopic Ultrasound Needles Segment Analysis
In this report, the Global Endoscopic Ultrasound Needles Market has been segmented by Product, Application, End Users and Geography.
Global Endoscopic Ultrasound Needles Market, Segmentation by Product
The Global Endoscopic Ultrasound Needles Market has been segmented by Product into Aspiration Needles (EUS-FNA) and Biopsy Needles (EUS-FNB).
The Global Endoscopic Ultrasound Needles Market has experienced significant segmentation based on products, primarily categorized into Aspiration needles (EUS-FNA) and Biopsy needles (EUS-FNB). Endoscopic ultrasound (EUS) procedures have become increasingly vital in diagnosing and staging various gastrointestinal and non-gastrointestinal diseases. These procedures involve the use of specialized needles for tissue sampling, fluid aspiration, and therapeutic interventions. The segmentation of the market into aspiration needles (EUS-FNA) and biopsy needles (EUS-FNB) reflects the distinct functionalities and applications of these products within the realm of endoscopic ultrasound.
Aspiration needles, also known as fine-needle aspiration (FNA) needles, are designed for the collection of tissue samples or aspirates from targeted lesions or abnormalities detected during EUS examinations. These needles typically feature a thin, flexible design with a sharp tip and are used to extract cells or fluid from organs such as the pancreas, lymph nodes, liver, and other gastrointestinal structures. Aspiration needles play a critical role in the diagnosis of various malignancies, including pancreatic cancer, lymphoma, and gastrointestinal tumors, by enabling clinicians to obtain cytological samples for pathological analysis. The market for aspiration needles is driven by the increasing incidence of cancer, advancements in EUS technology, and the growing adoption of minimally invasive diagnostic techniques.
Biopsy needles, on the other hand, are specialized devices designed for the acquisition of tissue core samples during EUS-guided biopsy procedures. These needles feature cutting edges or serrated tips that enable the collection of intact tissue specimens for histological examination. Biopsy needles are commonly used for the characterization and histopathological evaluation of suspicious lesions, such as pancreatic masses, submucosal tumors, and mediastinal lymph nodes. Unlike aspiration needles, which primarily yield cytological samples, biopsy needles provide clinicians with tissue architecture and cellular details necessary for accurate diagnosis and treatment planning. The market for biopsy needles is fueled by the growing demand for precise tissue sampling, advancements in needle design and technology, and the expanding applications of EUS-guided biopsy in oncology, gastroenterology, pulmonology, and interventional radiology.
Global Endoscopic Ultrasound Needles Market, Segmentation by Application
The Global Endoscopic Ultrasound Needles Market has been segmented by Application into Bronchial Needles and Enteral Needles.
Bronchial needles are primarily used in endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) procedures related to the examination of lesions and lymph nodes in the lungs and mediastinum. Lung cancer diagnosis, staging, and assessment of mediastinal lymph nodes for various malignancies are among the key applications of bronchial needles. The increasing prevalence of respiratory diseases, such as lung cancer, and the growing adoption of minimally invasive diagnostic techniques are driving the demand for bronchial needles in the global market.
Enteral needles are designed for use in endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) procedures involving the examination of lesions in the gastrointestinal (GI) tract, pancreas, liver, and other abdominal organs. These needles play a crucial role in the diagnosis and staging of gastrointestinal malignancies, assessment of pancreatic lesions, and sampling of lymph nodes and cysts in the abdomen. The rising incidence of GI disorders, including pancreatic cancer, gastrointestinal stromal tumors (GISTs), and pancreatic cysts, is fueling the demand for enteral needles worldwide.
Factors such as increasing investments in healthcare infrastructure, rising healthcare expenditure, growing awareness about minimally invasive diagnostic techniques, and expanding applications of endoscopic ultrasound procedures across various medical specialties are expected to sustain the growth momentum of the global endoscopic ultrasound needles market in the coming years. Strategic collaborations, partnerships, and acquisitions by key players in the market are likely to contribute to market expansion and product innovation, fostering competition and driving technological advancements in the field of endoscopic ultrasound-guided interventions.
Global Endoscopic Ultrasound Needles Market, Segmentation by End Users
The Global Endoscopic Ultrasound Needles Market has been segmented by End Users into Hospitals, Ambulatory Surgical Centers and Specialty Clinics.
Hospitals serve as the primary end users of endoscopic ultrasound (EUS) needles due to their extensive infrastructure, availability of skilled healthcare professionals, and the ability to handle complex medical procedures. These facilities often have specialized departments equipped with advanced endoscopic equipment, including ultrasound systems and needles, to perform diagnostic and therapeutic procedures effectively. Additionally, hospitals cater to a wide range of patient populations, including those requiring specialized care for gastrointestinal conditions, cancer, and other diseases where EUS procedures are indicated.
Ambulatory Surgical Centers (ASCs) are gaining traction as important end users of EUS needles, particularly for outpatient procedures. ASCs offer several advantages such as convenience, cost-effectiveness, and shorter wait times compared to traditional hospital settings. Moreover, advancements in technology have made it feasible to perform certain EUS procedures in ASCs, thereby expanding the market presence of EUS needles. The shift towards ambulatory care settings is driven by factors such as increasing emphasis on reducing healthcare costs, improving patient experience, and facilitating quicker recovery.
Specialty Clinics focusing on gastroenterology and oncology also represent a significant end user segment for EUS needles. These clinics specialize in providing comprehensive care for patients with gastrointestinal disorders, pancreatic diseases, liver conditions, and various cancers. EUS procedures play a vital role in the diagnosis, staging, and treatment of such conditions, making specialty clinics important customers for EUS needle manufacturers. Furthermore, specialty clinics often have dedicated teams of gastroenterologists, oncologists, and interventional radiologists proficient in performing EUS-guided interventions, contributing to the demand for high-quality EUS needles.
Global Endoscopic Ultrasound Needles Market, Segmentation by Geography
In this report, the Global Endoscopic Ultrasound Needles Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Endoscopic Ultrasound Needles Market Share (%), by Geographical Region, 2024
North America holds a prominent position in the global endoscopic ultrasound needles market, attributed to factors such as the presence of well-established healthcare infrastructure, high adoption of advanced medical technologies, and increasing prevalence of gastrointestinal diseases such as pancreatic cancer and gastrointestinal stromal tumors (GIST). Additionally, the rising geriatric population in this region, coupled with a growing awareness about early disease diagnosis and treatment options, further fuels the demand for endoscopic procedures and related devices. Europe follows North America in terms of market share, driven by factors including favorable reimbursement policies, technological advancements in endoscopic ultrasound procedures, and increasing investments in healthcare infrastructure. Countries such as Germany, France, and the United Kingdom are witnessing substantial growth in the adoption of endoscopic ultrasound needles due to a high burden of gastrointestinal diseases and favorable government initiatives aimed at improving healthcare access and quality.
The Asia Pacific region is poised for significant growth in the endoscopic ultrasound needles market, fueled by factors such as the rising prevalence of gastrointestinal disorders, increasing healthcare expenditure, and expanding healthcare infrastructure in countries like China, India, and Japan. Moreover, growing awareness about the benefits of early disease detection and advancements in minimally invasive surgical techniques are driving the adoption of endoscopic procedures, thereby boosting the demand for endoscopic ultrasound needles in the region. In the Middle East and Africa region, the market for endoscopic ultrasound needles is witnessing steady growth, supported by improving healthcare infrastructure, rising investments in healthcare facilities, and increasing prevalence of gastrointestinal disorders. However, challenges such as limited access to advanced medical technologies and healthcare services in certain regions may hinder market growth to some extent.
Latin America represents a growing market for endoscopic ultrasound needles, driven by factors such as the increasing incidence of gastrointestinal cancers, expanding healthcare infrastructure, and rising healthcare expenditure in countries like Brazil and Mexico. Moreover, initiatives aimed at raising awareness about early disease detection and improving healthcare access are expected to further fuel market growth in the region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Endoscopic Ultrasound Needles Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers, Restraints and Opportunity Analysis
Drivers
- Rising Prevalence of Gastrointestinal Diseases
- Advancements in Endoscopic Ultrasound Technology
-
Increasing Preference for Minimally Invasive Procedures - The global endoscopic ultrasound needles market is witnessing substantial growth, primarily driven by the increasing preference for minimally invasive procedures. Minimally invasive techniques have gained popularity among both healthcare providers and patients due to their numerous advantages over traditional surgical approaches. Endoscopic ultrasound (EUS) procedures, in particular, have emerged as a preferred choice for diagnosing and treating various gastrointestinal (GI) and pulmonary conditions.
Unlike conventional surgeries that often require large incisions and prolonged hospital stays, EUS procedures involve the insertion of a thin, flexible endoscope equipped with an ultrasound probe through natural orifices such as the mouth or anus. This minimizes tissue trauma, leading to shorter recovery periods, less pain, and lower risk of infections. The ability of endoscopic ultrasound to provide high-resolution imaging and precise tissue sampling has made it indispensable in the diagnosis and staging of GI cancers, pancreatic disorders, and other conditions. EUS-guided fine-needle aspiration (FNA) and fine-needle biopsy (FNB) techniques allow clinicians to obtain tissue samples from deep-seated lesions with exceptional accuracy, thereby facilitating timely diagnosis and appropriate treatment planning.
Another significant factor driving the uptake of endoscopic ultrasound needles is the expanding applications of EUS beyond traditional diagnostic procedures. With advancements in technology and technique refinement, EUS has evolved into a therapeutic modality for performing interventions such as drainage of pancreatic pseudocysts, celiac plexus neurolysis for pain management, and tumor ablation using radiofrequency or cryotherapy. As the scope of EUS continues to broaden, the demand for specialized needles capable of delivering therapeutic agents and facilitating complex procedures is expected to rise.
Restraints
- High Cost of Endoscopic Ultrasound Procedures
- Limited Reimbursement Policies
-
Requirement for Skilled Operators - Performing EUS procedures necessitates a high level of technical expertise and experience due to the complexity involved in maneuvering the endoscope and accurately interpreting the ultrasound images. These procedures involve inserting a specialized ultrasound probe into the gastrointestinal tract via an endoscope to obtain detailed images of internal organs and tissues. Precise positioning of the ultrasound needle is crucial for obtaining accurate diagnostic information or performing therapeutic interventions such as biopsies or fluid aspiration.
The skill required to perform EUS procedures proficiently cannot be understated. It demands extensive training, hands-on experience, and familiarity with the equipment and techniques involved. Skilled operators must possess a thorough understanding of anatomy, ultrasound imaging principles, and the ability to navigate through challenging anatomical structures safely. The shortage of adequately trained and experienced EUS operators poses a significant constraint on the widespread adoption and utilization of EUS procedures. Limited availability of skilled personnel can lead to longer wait times for patients, hinder timely diagnosis and treatment, and potentially compromise patient outcomes.
The training process for becoming proficient in EUS procedures is intensive and time-consuming. It typically involves formal education, specialized training programs, mentorship under experienced practitioners, and a considerable learning curve. The limited pool of individuals willing to undergo such rigorous training further exacerbates the shortage of skilled operators.
Opportunities
- Rising Prevalence of Gastrointestinal and Pancreatic Disorders
- Expanding Applications in Oncology
-
Focus on Patient Safety and Comfort - One significant opportunity within this market lies in enhancing patient safety throughout the entire procedure. Manufacturers and healthcare professionals are increasingly focusing on developing and adopting technologies and techniques that minimize risks associated with endoscopic ultrasound procedures. This includes innovations in needle design to reduce the likelihood of complications such as bleeding, perforation, and infection. Additionally, advancements in imaging technologies allow for real-time visualization during needle insertion, enhancing precision and reducing the chance of errors.
There is a growing emphasis on improving patient comfort during endoscopic ultrasound procedures. These procedures can be physically and emotionally challenging for patients, leading to anxiety and discomfort. Therefore, there's a push to develop needles and equipment that prioritize patient comfort without compromising procedural efficacy. This includes the design of needles with smoother surfaces and finer gauges, as well as the integration of features such as vibration reduction mechanisms to minimize pain and tissue trauma.
Efforts are underway to optimize procedural techniques and protocols to enhance patient comfort and overall experience. This may involve the use of sedation and anesthesia protocols tailored to individual patient needs, as well as the implementation of patient-centered care approaches that prioritize communication, empathy, and support throughout the procedure. The emphasis on patient safety and comfort not only enhances the quality of care but also contributes to higher patient satisfaction levels and better clinical outcomes. Healthcare providers are increasingly recognizing the importance of delivering patient-centric care, and investments in technologies and practices that prioritize safety and comfort during endoscopic ultrasound procedures are likely to drive growth and innovation within the global market.
Competitive Landscape Analysis
Key players in Global Endoscopic Ultrasound Needles Market include:
- Medtronic PLC
- CONMED Corporation
- Olympus Corporation
- Boston Scientific Corporation
- Cook Group Incorporated
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Global Endoscopic Ultrasound Needles Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Rising Prevalence of Gastrointestinal Diseases
-
Advancements in Endoscopic Ultrasound Technology
-
Increasing Preference for Minimally Invasive Procedures
-
- Restraints
-
High Cost of Endoscopic Ultrasound Procedures
-
Limited Reimbursement Policies
-
Requirement for Skilled Operators
-
- Opportunities
-
Rising Prevalence of Gastrointestinal and Pancreatic Disorders
-
Expanding Applications in Oncology
-
Focus on Patient Safety and Comfort
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Endoscopic Ultrasound Needles Market, By Product, 2021 - 2031 (USD Million)
-
Aspiration Needles (EUS-FNA)
-
Biopsy Needles (EUS-FNB)
-
- Global Endoscopic Ultrasound Needles Market, By Application, 2021 - 2031 (USD Million)
-
Bronchial Needles
-
Enteral Needles
-
- Global Endoscopic Ultrasound Needles Market, By End Users, 2021 - 2031 (USD Million)
-
Hospitals
-
Ambulatory Surgical Centers
-
Specialty Clinics
-
- Global Endoscopic Ultrasound Needles Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Endoscopic Ultrasound Needles Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Medtronic PLC
- CONMED Corporation
- Olympus Corporation
- Boston Scientific Corporation
- Cook Group Incorporated
- Company Profiles
- Analyst Views
- Future Outlook of the Market